Surface chemistry controls the selective nucleation of crystal polymorphs of a pharmaceutical drug
Reliable batch-to-batch formation is crucial for crystalline, active pharmaceutical ingredients as two different polymorphs of the same drug may function very differently in the body. Sendhil Poornachary from the A*STAR Institute of Chemical and Engineering Sciences and colleagues now report that the surface chemistry of modified glass substrates can influence the nucleation and formation of specific polymorphs of the drug, carbamazepine, within a certain concentration range of supersaturated solutions1.
The isolation of a specific polymorph is usually achieved by controlling homogeneous crystal nucleation. However, heterogeneous nucleation — which relies on the presence of a nucleating surface — is more ‘thermodynamically favorable’, meaning less energy is required. The most common heterogeneous method is to add seed crystals to a solution, but problems such as inconsistencies in seed crystal properties and cross-nucleation between crystal polymorphs may result in unwanted polymorphs.
Poornachary and team show that modified glass surfaces can selectively nucleate two different polymorphic forms of carbamazepine, an anticonvulsant and mood-stabilizing drug. “This concept of template-induced crystallization shows promise for improving batch-to-batch reproducibility with respect to the crystal form obtained,” says Poornachary.
The researchers produced cyano-, mercapto- and fluoro-functionalized glass vials by altering the interior surface using a silanization method, and then observed crystallization of the drug from supersaturated ethanol solutions. The two polymorphs were easily distinguished; either needle-shaped crystals corresponding to the metastable form II or tetrahedral-shaped crystals of the more energetically stable form III (see image).
The researchers found that at an initial drug concentration of 60 milligrams per milliliter, the metastable form II crystals were preferentially formed on the cyano-surface with no evidence of the crystals transforming to the more stable polymorph even after 24 hours. The mercapto- and fluoro-surfaces, however, preferentially nucleated form III with a small amount of metastable form II. In control vials, both polymorphs crystallized in tandem and transformed to the stable form within 24 hours. The time taken for the first crystals to appear was similar for all three modified surfaces, and significantly faster than in the control vials.
“We plan to improve our fundamental understanding of this template-induced crystallization process through molecular modeling and simulation,” says Poornachary.
The researchers envisage that better knowledge of the molecular packing arrangements in the crystal polymorphs — along with an enhanced understanding of crystal nucleation — may enable the design of template substrates with specific chemistries, eventually improving polymorphic selectivity for a variety of active pharmaceutical ingredients.
“We are also exploring scale-up of the template-induced crystallization approach using functionalized seed crystals and template particles,” added Poornachary.
The A*STAR-affiliated researchers contributing to this research are from the Institute of Chemical and Engineering Sciences
Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland
Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy